Teva prices $4.9bn equivalent senior notes, issues five tranches maturing 2032—2037
Teva priced approximately $4.9 billion (equivalent) of senior notes across five tranches and expects settlement on or about September 16, 2026.Key Highlights:Original SEC Filing: TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ] - 8-K - Sep. 11, 2026This is an AI-powered summary. It may contain inaccurac…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.